The proliferation of "unicorn" startups in the financial technology sector during the late 2010s was largely underpinned by a low-interest-rate environment that incentivized venture capital (VC) firms to seek aggressive growth over immediate profitability. However, as central banks adjusted monetary policies to combat inflation, the cost of capital rose, precipitating a wave of "down rounds," funding events where a company's valuation is lower than in previous rounds. Traditional analysis suggests that down rounds primarily signal a failure of the startup’s business model. Yet, this view overlooks the role of liquidity preferences among institutional investors. In many instances, the valuation haircut is a tactical concession by founders to secure the "dry powder" necessary to survive a protracted market contraction rather than an indictment of the firm's core technological offering. Moreover, "pay-to-play" provisions, clauses that penalize existing investors who decline to participate in subsequent rounds, often distort market signals, as participation may be driven by the desire to avoid dilution rather than a genuine belief in the startup's recovery. Consequently, evaluating a fintech firm's health solely through its valuation trajectory provides an incomplete, and potentially deceptive, diagnostic of its long-term viability.